Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

Effect of Histone Deacetylase Inhibitor MGCD0103 on Hepatocellular Carcinoma Cell Line BEL7402 in Vitro

Down-regulation of HDAC5 inhibits growth of human hepatocellular carcinoma by induction of apoptosis and cell cycle arrest

Histone deacetylase inhibitor MGCD0103 causes cell cycle arrest, apoptosis, and autophagy in liver cancer cells

[Effects of Hepatocyte Growth Factor Gene Transfection on Adriamycin-Induced Apoptosis of Gastric Cancer Cells in Vitro].

Effect of 5-Azn-2'-deoxycytidine on Proliferation of Human Lung Adenocarcinoma Cell Line A549 in Vitro

In vitro and in vivo study of BZG-4000: Anti-tumoral activity of human hepatocellular carcinoma

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Inhibitory Effect of EGFR Antisense Oligodeoxynucleotide on Human Hepatoma Cell Line.

Effect of lithium chloride on proliferation and cell cycle of human hepatoma cells

Growth inhibitory effects of Chidamide on breast cancer cells

Inhibiting Effect of Mitomycin C on Human Nasopharyngeal Carcinoma Cell Line HNE2、HNE2/lmp1 and Its Mechanism

Inhibitory effects of icaritin on proliferation of three human carcinoma cell lines

Antitumor activity of Chidamide in hepatocellular carcinoma cell lines

The effect of fibronectin and arginine-glycine-aspartic-serine tetrepeptide on chemotherapy sensitivity of liver carcinoma cell lines

1 α ,25 (OH)2D3 inhibits proliferation of gastric cancer cell line by arresting cell cycle

Inhibitory Effect of Vitexicarpin on Proliferation of Pituirary Adenoma GH3 Cells

INHIBITION OF MYRICETIN ON HUMAN LUNG ADENOCARCINOMA H460 CELL PROLIFERATION AND THE ROLE OF ERK PATHWAY

Effects of Ginsenoside Rg3 on growth and apoptosis of hepatic carcinoma cells lines in vitro

Antitumor Effect of Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Combined with Cytotoxic Agent on Murine Hepatocellular Carcinoma

Anti-proliferative Effects of Curcumin on Human Hepatocellular Carcinoma HepG2 and Bel-7404 Cells

The Inhibitory Effect of 3Β-Hydroxy-12-oleanen-27-oic Acid on Growth and Motility of Human Hepatoma HepG2 Cells Through JNK and Akt Signaling Pathway